Search

everythinglearnresearchcommunity

for

Search:↓

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

Proper diet management is crucial for preventing severe symptoms in phenylketonuria.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

A new EDA gene mutation was found in a Chinese family with a specific skin disorder.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

Older adults on certain medications should be carefully monitored for urinary issues and low sodium levels.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Chikungunya virus often causes skin issues and inflammation.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Metformin is less effective in men with early-onset hair loss.